• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

This Week in Aesthetics: June 8-12


In case you missed it, this week we covered Instagram’s updated content restrictions, ISHRS’s hair restoration survey and more.

this week in aesthetics

This week in aesthetics, Instagram’s updated content restrictions cause marketing shifts, ISHRS survey shows growth in hair restoration, a flap technique prevents nipple dyspigmentation for MWL patients, our legal panel discuss choosing the right mask and avoiding legal landmines, and Revance, in partnership with Mylan, collaborate on a biosimilar to Botox.

Cloth Mask, Surgical Mask or N95 respirator?

Experts on our legal panel discuss the primary purpose of wearing a mask, which ones are the correct choice based on specific situations and whether plume presents a liability risk.

Words of Wisdom for Avoiding Legal Landmines During COVID-19

Our experts offer words of wisdom for avoiding legal landmines during COVID-19

Instagram’s Content Restrictions Mean Practice Marketing Changes

Private practices may need to rethink their marketing tactics based on Instagram’s content restrictions and the COVID-19 environment.

ISHRS Survey Shows Steady Growth in Hair Restoration

The International Society of Hair Restoration Surgery (ISHRS) reports steady increases in both surgical and nonsurgical hair restoration procedures and highlights their public awareness campaign to crack down on illegal hair restoration clinics

Flap Technique Prevents Nipple Dyspigmentation in Male MWL Patients of Color

A study describes surgical experience with a modified elliptical excision and NAC transfer to prevent nipple dyspigmentation in male MWL patients undergoing breast reduction.

Revance, Mylan Collaborate on a Biosimilar to Botox

Revance recently announced their partnership with Mylan on the development of a possible biosimilar to Botox under the 351(k) regulatory pathway.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.